[DISCLOSURE] ST Pharm (237690) repoted on July 27 that its consolidated operating profit soared 548.2 percent on-year, reaching 31.21 billion won (US$27.49 million). Sales and net profit in the period surged 621.5 percent and 129.8 percent, respectively, amounting to 23.72 billion and 69.77 billion won.